NFKB1 and neoplasm: Han et al. found that the inhibition of the NF-κB pathway is partly due to the DDB2-induced upregulation of IκBα expression (an inhibitor of NF-κB) in OC cells and ovarian CSCs, which inhibits the self-renewal ability of ovarian CSCs and eventually leads to tumor progression disorder.